Is #ketamine a #psychedelic ? https://psychedelicmentalhealth.net/is-ketamine-a-psychedelic/ #psychedelics #ketaminetherapy #psychedelicassistedpsychotherapy #ketamineassistedpsychotherapy
Did you know ketamine was coined a "dissociative anesthetic" by the wife of the chemist who first synthesized it lest its potential use in medicine be ruined due to its association with "classical psychedelics"?
"A systematic review of PO and SL ketamine noted no significant side effects, and no problems with tolerance or substance misuse in any of the studies, which totaled 140 patients who received ketamine up to 3 years in duration…” (Swainson, 2022)
Psychedelic and psychiatric medicines have been studied for over 100 years as adjuncts to psychotherapy, with over 60 years of ongoing research on the off-label use of racemic ketamine, a generic medicine in various routes of administration with varying levels of support care
A first-of-its-kind clinical trial shows that ketamine treatment for severe, treatment-resistant depression is significantly more effective when paired with psychotherapy and supportive environments. Patients who underwent combined treatment reported a 30% drop in symptoms lasting at least 8 weeks
"A systematic review of PO and SL ketamine noted no significant side effects, and no problems with tolerance or substance misuse in any of the studies, which totaled 140 patients who received ketamine up to 3 years in duration…” (Swainson, 2022)
Dr. Michael DeMarco is a licensed mental health and family therapist and has pursued additional training in the use of psychedelic medicines for those struggling with substance use disorders. He emphasizes that there has been a significant amount of research about the use of Ketamine and other medications over the course of decades, and it's important to know how to put such research in an appropriate context. In this podcast, Michael talks about his own interest in the recovery ecosystem and the journey he has embarked on in the pursuit of helping others. He also relates his extensive background in cognitive behavioral therapy to his current Ketamine-assisted therapy practice. Additional information:
KAP produced sustained reductions in anxiety, depression, and PTSD, with symptom improvement lasting well beyond the duration of dosing and integration sessions. These effects extended to as much as 5 months after the last KAP session. However, the high rates of attrition may limit validity of the r …
Psychedelic Institute
